AeroLeads people directory · profile

Catherine Deacon Email & Phone Number

Senior Director, Research and Development Finance, Therapeutic Area Units at Takeda
Location: Cambridge, Massachusetts, United States 9 work roles 3 schools
LinkedIn matched
✓ Verified August 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Takeda
Role
Senior Director, Research and Development Finance, Therapeutic Area Units
Location
Cambridge, Massachusetts, United States

Who is Catherine Deacon? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Catherine Deacon is listed as Senior Director, Research and Development Finance, Therapeutic Area Units at Takeda, based in Cambridge, Massachusetts, United States. AeroLeads shows a matched LinkedIn profile for Catherine Deacon.

Catherine Deacon previously worked as Senior Director, Portfolio Strategy and Finance Operations at Takeda Pharmaceuticals International, Inc. and Director, R&D Controlling, Worldwide Development Programs at Emd Serono, Inc.. Catherine Deacon holds Mba, Finance from University Of Connecticut.

Company email context

Email format at Takeda

This section adds company-level context without repeating Catherine Deacon's masked contact details.

Takeda

Review company-level records connected to Catherine Deacon before choosing the right outreach path.

View email format View company profile Management contacts
Profile bio

About Catherine Deacon

Catherine is a financial executive in the global biopharmaceutical industry with over 20 years of leadership in research and development finance and business development currently responsible for financial leadership of the 4 therapeutic areas of Takeda: Oncology, Neuroscience, Gastro Intestinal, and Rare Diseases.Catherine joined Takeda in 2017 and her current role is Senior Director of Finance, Therapeutic Asset Units, Research and Development with financial and strategic leadership for 4 Therapeutic Asset Portfolios: Oncology, Neuroscience, Gastrointestinal and Rare Disease encompassing all PH I-IV development assets, portfolio development , and external partnerships. Prior to Takeda, she was with EMD Serono from 2013 - 2017 as Head of Controlling US for Global Research and Development with responsibility for early and late stage R&D programs and external collaborations. Prior to EMD Catherine was with Pfizer for 10 years, in finance leadership roles in R&D, including financial planning, budgeting, analysis, and the lead for an integration, and for the Center for Integrative Biologics and Biolomics Research Unit, and for the Inflammation and Remodeling Research Unit . Prior to Pfizer, Catherine was the Chief financial officer for a medical start-up focused, and served as Controller, Director of Finance, Domestic and International, and Finance lead for the Marketing Division for Pitney Bowes.External activities include Board of Director roles for the Center for the Arts, and a life long history of volunteering and activism for community health, education and the underserved populations.

Current workplace

Catherine Deacon's current company

Company context helps verify the profile and gives searchers a useful next step.

Takeda
Takeda
Senior Director, Research and Development Finance, Therapeutic Area Units
AeroLeads page
Company profile
View company profile Email format
9 roles

Catherine Deacon work experience

A career timeline built from the work history available for this profile.

Senior Director, Research And Development Finance, Therapeutic Area Units

Current
Takeda

Tokyo, Jp

Financial Leadership and strategic planning for the 4 therapeutic asset areas within Takeda: Oncology, Neuroscience, Gastrointestinal and Rare Diseases. Responsible for budgeting, planning, evaluations, NPV analysis, prioritization, decision making on programs, and long range forecast for all asset programs PH I-IV. Manage external partnerships, co development of assets with multiple global partners. Preparation and presentation to R&D leadership for investments into potential asset development.

Sep 2021 - Present

Senior Director, Portfolio Strategy And Finance Operations

Takeda Pharmaceuticals International, Inc.

Financial and strategic leadership for Financial Planning & Analysis for Global R&D . Member of the R&D Steering Committee, and the Executive Committee for External Partnerships, and Diversity and Inclusion lead. Manage a direct international staff of 16 to include North America, Europe and Asia,Indirect staff: 3000 Budget : 2 Billion; 1B in external investmentsFinancial and strategic leadership for the Worldwide Asset enabling functions to include:Global Regulatory AffairsGlobal Patient and Safety EvaluationGlobal Medical AffairsGlobal Clinical OperationsMarketed Products R&DGlobal Data ScienceGlobal Quality Assurance

Mar 2017 - Sep 2021

Director, R&D Controlling, Worldwide Development Programs

Emd Serono, Inc.

Boston, Massachusetts, Us

Strengths: Finance Leadership, financial planning and analysis, reporting, internal controls, governance processes, operating plan development, business partnering and collaboration with scientific leads, cross functional collaboration, change management, providing direction and clarity in a matrix environment, process improvement. Worldwide responsibility for late stage research and development programs; ( PHI through PH IV), external collaborations. Portfolio evaluation and prioritization, operating plan, strategic planning, budgeting, forecasting over multi year horizon for worldwide programs. Lead multiple cross functional initiatives. Represent EMD to top three external collaborations, including premier partnership in the history of Pharma. Accomplishments include design and lead operating plan process, development and implementation of a new R&D project demand planning and forecasting model, cross team coordination and implementation of planisware, build a US team to support growth in domestic market. Budget; $1B; staff: US 5 Europe 3

Jan 2015 - Mar 2017

Senior Controller, Research And Development

Emd Serono, Inc.

Boston, Massachusetts, Us

Jul 2013 - Jan 2015

Associate Director, Finance, Biotherapeutics Research

Pfizer

New York, New York, Us

Jan 2010 - Jul 2013

Manager,Finance, Oncology Business Unit

Pfizer

New York, New York, Us

Jan 2009 - Jan 2010

Senior Portfolio Liaison, Finance And Technology

Pfizer

New York, New York, Us

Jan 2008 - Jan 2009

Chief Financial Officer

Cww
Jan 2006 - Jan 2007

Controller

Pitney Bowes

Stamford, Ct, Us

Jul 1989 - Dec 2004
3 education records

Catherine Deacon education

Mba, Finance

University Of Connecticut

Masters Of Science, Quality Affairs/Regulatory Assurance

Temple University School Of Pharmacy

Bachelors Of Science, Finance

University Of Connecticut
FAQ

Frequently asked questions about Catherine Deacon

Quick answers generated from the profile data available on this page.

What company does Catherine Deacon work for?

Catherine Deacon works for Takeda.

What is Catherine Deacon's role at Takeda?

Catherine Deacon is listed as Senior Director, Research and Development Finance, Therapeutic Area Units at Takeda.

Where is Catherine Deacon based?

Catherine Deacon is based in Cambridge, Massachusetts, United States while working with Takeda.

What companies has Catherine Deacon worked for?

Catherine Deacon has worked for Takeda, Takeda Pharmaceuticals International, Inc., Emd Serono, Inc., Pfizer, and Cww.

How can I contact Catherine Deacon?

You can use AeroLeads to view verified contact signals for Catherine Deacon at Takeda, including work email, phone, and LinkedIn data when available.

What schools did Catherine Deacon attend?

Catherine Deacon holds Mba, Finance from University Of Connecticut.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.